Clinical Pharmacy Services in Ambulatory Oncology: An Environmental Scan of the Canadian Practice Landscape

被引：3

作者：

Tibensky, Bryanna ^{[1
,2
]}

Hutton, Lauren ^{[3
,4
]}

Wentzell, Jason ^{[2
,5
]}

LeBlanc, Michael ^{[6
]}

Edwards, Scott ^{[7
,8
]}

McFarlane, Thomas ^{[2
]}

机构：

[1] Univ Waterloo, Ctr Family Med Family Hlth Team, Waterloo, ON, Canada

[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada

[3] Nova Scotia Hlth, Halifax, NS, Canada

[4] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada

[5] Extend Pharm & Extend Hlth Solut, Ottawa, ON, Canada

[6] Horizon Hlth Network, New Brunswick, NJ USA

[7] Eastern Hlth, St John, NL, Canada

[8] Mem Univ St Johns, St John, NL, Canada

来源：

CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2022年 / 75卷 / 04期

关键词：

clinical pharmacy key performance indicator; key performance indicator; ambulatory oncology; oncology pharmacy; outpatient oncology; Canada;

D O I：

10.4212/cjhp.3208

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background: Canadian clinical pharmacy key performance indicators (cpKPIs) have been developed for inpatient hospital practice but are not established for ambulatory oncology. This study represents the first step in developing cpKPIs for ambulatory oncology.Objectives: To describe the current landscape of pharmacy services in ambulatory oncology in Canada and to identify perspectives related to the development and implementation of cpKPIs in this practice setting.Methods: In this national cross-sectional study, a web-based questionnaire was distributed to pharmacists working in ambulatory oncology settings. Potential participants who self-identified as pharmacists practising in an ambulatory oncology setting were eligible. Survey questions focused on participants' demographic characteristics, oncology pharmacy services provided, metrics captured, and pharmacists' perceptions of cpKPIs. All data were analyzed using descriptive statistics.Results: A total of 44 responses were received, with most respondents practising in community hospitals in British Columbia, Ontario, and Atlantic Canada. The services most commonly provided were chemotherapy order verification, laboratory monitoring, identification and resolution of drug therapy problems, and counselling on anticancer medications. Twenty-six of the 44 respondents (59%) indicated that performance metrics or patient outcomes were tracked at their respective institutions, with none being universally captured. Overall, 43 (98%) of the respondents favoured the development of cpKPIs for ambulatory oncology practice.Conclusions: Despite growing patient care needs in ambulatory oncology, there is significant heterogeneity in the scope of pharmacy services offered and the outcomes used to qualify their impact within this setting across Canada. This study demonstrates a clear need for national consensus cpKPIs to inform pharmacy resource utilization and patient -centred quality improvement initiatives.

引用

页码：259 / 266

页数：8

共 36 条

[1] Fernandes O, Gorman SK, Slavik RS, Semchuk WM, Shalansky S, Bussieres JF, Et al., Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach, Ann Pharmacother, 49, 6, pp. 656-669, (2015)
[2] Lo E, Rainkie D, Semchuk WM, Gorman SK, Toombs K, Slavik RS, Et al., Measurement of clinical pharmacy key performance indicators to focus and improve your hospital pharmacy practice, Can J Hosp Pharm, 69, 2, pp. 149-155, (2016)
[3] Shawahna R., Development of key performance indicators to capture in measuring the impact of pharmacists in caring for patients with epilepsy in primary healthcare: a Delphi consensual study, Epilepsy Behav, 98, pp. 129-138, (2019)
[4] Lima TM, Aguiar PM, Storpirtis S., Development and validation of key performance indicators for medication management services provided for outpatients, Res Soc Adm Pharm, 15, 9, pp. 1080-1087, (2019)
[5] Holle LM, Michaud LB., Oncology pharmacists in health care delivery: vital members of the cancer care team, J Oncol Pract, 10, 3, pp. e142-e145, (2014)
[6] Schmidt L, Klink C, Iglar A, Sharpe N., Implementation of performance metrics to assess pharmacists' activities in ambulatory care clinics, Am J Health Syst Pharm, 74, 1, pp. e76-e82, (2017)
[7] Edwards S, Abbott R, Dranitsaris G., Patient monitoring programs in oncology pharmacy practice: a survey of oncology pharmacists in Atlantic Canada, J Oncol Pharm Pract, 25, 4, pp. 891-895, (2019)
[8] Maleki S, Alexander M, Fua T, Liu C, Rischin D, Lingaratnam S., A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies, J Oncol Pharm Pract, 25, 1, pp. 130-139, (2019)
[9] Colombo LRP, Aguiar PM, Lima TM, Storpirtis S., The effects of pharmacist interventions on adult outpatients with cancer: a systematic review, J Clin Pharm Ther, 42, 4, pp. 414-424, (2017)
[10] Ruder AD, Smith DL, Madsen MT, Kass FH., Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?, J Oncol Pharm Pract, 17, 4, pp. 425-432, (2011)

← 1 2 3 4 →